Adam H Schechter is EVP & Pres-Global Human Health of Merck & Co., Inc.. Currently has a direct ownership of 0 shares of MRK, which is worth approximately $0. The most recent transaction as insider was on Nov 01, 2018, when has been sold 277,879 shares (Common Stock) at a price of $73.82 per share, resulting in proceeds of $20,513,028. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Adam H Schechter Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2018
SELL
Open market or private sale
$20,513,028 $73.82 p/Share
277,879 Reduced 100.0%
0 Common Stock
Nov 01 2018
BUY
Exercise of conversion of derivative security
$10,917,866 $39.29 p/Share
277,879 Added 50.0%
277,879 Common Stock
Sep 17 2018
SELL
Open market or private sale
$7,018,000 $70.18 p/Share
100,000 Reduced 100.0%
0 Common Stock
Sep 17 2018
BUY
Exercise of conversion of derivative security
$3,656,000 $36.56 p/Share
100,000 Added 50.0%
100,000 Common Stock
Jun 18 2018
SELL
Open market or private sale
$6,100,000 $61.0 p/Share
100,000 Reduced 100.0%
0 Common Stock
Jun 18 2018
BUY
Exercise of conversion of derivative security
$3,656,000 $36.56 p/Share
100,000 Added 50.0%
100,000 Common Stock
Feb 27 2018
BUY
Grant, award, or other acquisition
$1,865,624 $54.72 p/Share
34,094 Added 50.0%
34,094 Common Stock
Jan 16 2018
SELL
Open market or private sale
$3,142,760 $61.63 p/Share
50,994 Reduced 100.0%
0 Common Stock
Jan 16 2018
BUY
Exercise of conversion of derivative security
$1,864,341 $36.56 p/Share
50,994 Added 50.0%
50,994 Common Stock
Feb 27 2017
BUY
Grant, award, or other acquisition
$2,632,024 $65.85 p/Share
39,970 Added 50.0%
39,970 Common Stock
Feb 03 2017
SELL
Open market or private sale
$2,315,630 $63.73 p/Share
36,335 Reduced 100.0%
0 Common Stock
Feb 03 2017
BUY
Exercise of conversion of derivative security
$1,272,815 $35.03 p/Share
36,335 Added 50.0%
36,335 Common Stock
Sep 01 2016
SELL
Open market or private sale
$2,454,312 $62.61 p/Share
39,200 Reduced 100.0%
0 Common Stock
Sep 01 2016
BUY
Exercise of conversion of derivative security
$1,312,808 $33.49 p/Share
39,200 Added 50.0%
39,200 Common Stock
Jul 01 2016
SELL
Open market or private sale
$2,884,500 $57.69 p/Share
50,000 Reduced 100.0%
0 Common Stock
Jul 01 2016
BUY
Exercise of conversion of derivative security
$2,215,000 $44.3 p/Share
50,000 Added 50.0%
50,000 Common Stock
Feb 22 2016
BUY
Grant, award, or other acquisition
$1,889,812 $50.77 p/Share
37,223 Added 50.0%
37,223 Common Stock
May 11 2015
SELL
Open market or private sale
$642,719 $60.44 p/Share
10,634 Reduced 100.0%
0 Common Stock
May 02 2015
SELL
Payment of exercise price or tax liability
$521,321 $59.86 p/Share
8,709 Reduced 45.02%
10,634 Common Stock
May 02 2015
BUY
Exercise of conversion of derivative security
-
19,343 Added 50.0%
19,343 Common Stock
Feb 23 2015
BUY
Grant, award, or other acquisition
$1,294,143 $58.3 p/Share
22,198 Added 50.0%
22,198 Common Stock
Jan 15 2015
SELL
Open market or private sale
$4,636,016 $62.48 p/Share
74,200 Reduced 100.0%
0 Common Stock
Jan 15 2015
BUY
Exercise of conversion of derivative security
$2,813,664 $37.92 p/Share
74,200 Added 50.0%
74,200 Common Stock
May 14 2014
SELL
Open market or private sale
$588,565 $55.91 p/Share
10,527 Reduced 100.0%
0 Common Stock
May 04 2014
SELL
Payment of exercise price or tax liability
$501,856 $58.22 p/Share
8,620 Reduced 45.02%
10,527 Common Stock

Also insider at

LH
LABORATORY CORP OF AMERICA HOLDINGS Healthcare
DVA
DAVITA INC. Healthcare
AHS

Adam H Schechter

EVP & Pres-Global Human Health
Kenilworth, NJ

Track Institutional and Insider Activities on MRK

Follow Merck & Co., Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRK shares.

Notify only if

Insider Trading

Get notified when an Merck & Co., Inc. insider buys or sells MRK shares.

Notify only if

News

Receive news related to Merck & Co., Inc.

Track Activities on MRK